About Veniti
Veniti is a Healthcare company based in St. Louis (United States) founded in 2010, and was acquired by Boston Scientific in August 2018. A self-expanding stent system for chronic venous disease is developed. Veniti has raised $65.22 million across 4 funding rounds from investors including Boston Scientific, Confluent Medical and Tekla Capital Management. Veniti has completed 1 acquisition, including Varix Medical. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Veniti inc. Its competitors include Tactile Medical, enVVeno Medical and DeVoro Medical; 2 of its 3 listed competitors have raised funding.
Company details
Veniti was established in 2010 in St. Louis, United States, within the medical device sector. Focus is placed on venous stents to address chronic venous disease. The VICI VENOUS STENT System includes a nitinol-based, laser-cut implant with closed-cell design, bridges, and braces for venous adaptability, alongside a coaxial over-the-wire delivery mechanism. Compatibility with 9Fr sheaths enables jugular or femoral access. Availability excludes the US market.
- Headquarters St. Louis, United States
- Stage Acquired
- SectorsHealthcare
- Website veniti.com
- Social LinkedIn X
- Acquired by Boston Scientific (Aug 2018)
- Legal Name Veniti Inc
- Total Equity Funding$65.22M (USD)
in 4 rounds
- Latest Funding Round$25M (USD), Series D
Sep 2016
- InvestorsBoston Scientific
& 8 more
- Investments & Acquisitions
- Acquired byBoston Scientific
(Aug 2018)
Funding Insights of Veniti
Veniti has successfully raised a total of $65.22M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $25 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $65.22M
- Total Rounds 4
- Last Round Series D — $25M
- First Round $13.5M
(Mar 2011)
- Investors Count 9
All 4 funding rounds of Veniti with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2016 | $25M | Series D | – | – | |
| Mar 2015 | $17M | Series C | – | – | |
| Jun 2013 | $9.72M | Series B | – | – | – |
| Mar 2011 | $13.5M | Series A | – | – |
9 investors in total: 9 institutional.
Investors in Veniti
Veniti has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Boston Scientific, Confluent Medical and Tekla Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| lsafunding.com | ||||
| volcanocap.com | ||||
Health-focused venture capital investments are made in US sectors. | prologventures.com | Newark, United States | ||
Investments are made by CD-Venture in early-stage life sciences startups. | cd-venture.com | Heidelberg, Germany | ||
Early-stage businesses are funded by St. Louis Arch Angels. | 2005 | stlouisarchangels.com | St. Louis, United States | |
Global private equity and venture capital investments in B2B Tech & Services companies. | bairdcapital.com | |||
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States | |
Investment advisory services are provided to financial clients. | 1986 | teklacap.com | Boston, United States | |
Advanced materials are used in manufacturing medical devices and implants. | 1991 | confluentmedical.com | Fremont, United States |
Investor details for Veniti
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Veniti
Veniti has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Varix Medical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Innovative steam-based devices for varicose vein treatment are developed. | varixmedical.com | Sunnyvale, United States | 2007 | Mar 2011 | •••• |
Complete acquisition details for Veniti
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Veniti
5 dated milestones of Veniti across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Veniti is founded.
- Funding First funding round of $13.5M.
- Acquisition Acquires Varix Medical.
- Funding Latest funding round, Series D, of $25.0M.
- Exit Acquired by Boston Scientific.
Competitors of Veniti
Veniti has 3 listed competitors in our database, 2 of them funded. They include Tactile Medical, enVVeno Medical and DeVoro Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tactilemedical.com | 1995 | Minneapolis, United States | $23.2M | 592 | Home therapy devices for lymphedema and venous ulcers are provided. | |
| envveno.com | 1999 | Irvine, United States | 31 | Developer of medical device for the the treatment of venous diseases | ||
| devoromedical.com | 2018 | Fremont, United States | $18M | Medical devices for treating cardiac diseases are developed. |
Detailed competitors of Veniti
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Veniti (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Veniti
Complete news archive for Veniti
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veniti
Veniti was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Veniti is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Veniti is a funded company, having raised a total of $65.22M across 4 funding rounds to date. The company's 1st funding round was a Series A of $13.5M, raised on Mar 2011.
Veniti was established in 2010 in St. Louis, United States, within the medical device sector. Focus is placed on venous stents to address chronic venous disease. The VICI VENOUS STENT System includes a nitinol-based, laser-cut implant with closed-cell design, bridges, and braces for venous adaptability, alongside a coaxial over-the-wire delivery mechanism. Compatibility with 9Fr sheaths enables jugular or femoral access. Availability excludes the US market.
Veniti's top competitors include Tactile Medical, enVVeno Medical and DeVoro Medical.
Veniti has made 1 acquisition, including Varix Medical.
Veniti has 9 investors. Key investors include Boston Scientific, Confluent Medical, Tekla Capital Management, Life Sciences Alternative Funding, and Volcano Capital Management.
Veniti operates through Veniti Inc.
Yes. Veniti was acquired by Boston Scientific in August 2018.